EA201692334A1 - Кортикостероидные композиции для местного применения - Google Patents
Кортикостероидные композиции для местного примененияInfo
- Publication number
- EA201692334A1 EA201692334A1 EA201692334A EA201692334A EA201692334A1 EA 201692334 A1 EA201692334 A1 EA 201692334A1 EA 201692334 A EA201692334 A EA 201692334A EA 201692334 A EA201692334 A EA 201692334A EA 201692334 A1 EA201692334 A1 EA 201692334A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compositions
- local application
- corticosteroid compositions
- corticosteroid
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Abstract
Описаны композиции для местного введения активного агента, содержащие кортикостероид и жирный спирт в качестве интенсификатора проникновения через кожу, в форме распыляемых композиций для местного применения. Способы получения таких композиций и способы их использования для лечения кожных заболеваний или нарушений, таких как псориаз, дерматозы и другие сопутствующие кожные заболевания или нарушения.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461951165P | 2014-03-11 | 2014-03-11 | |
US14/645,338 US20150258119A1 (en) | 2014-03-11 | 2015-03-11 | Topical corticosteroid compositions |
PCT/US2015/020031 WO2015138650A1 (en) | 2014-03-11 | 2015-03-11 | Topical corticosteroid compositions |
PCT/US2015/049244 WO2016144381A1 (en) | 2014-03-11 | 2015-09-09 | Topical corticosteroid compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201692334A1 true EA201692334A1 (ru) | 2018-02-28 |
Family
ID=52727460
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201691808A EA201691808A8 (ru) | 2014-03-11 | 2015-03-11 | Кортикостероидные композиции для местного применения |
EA201692334A EA201692334A1 (ru) | 2014-03-11 | 2015-09-09 | Кортикостероидные композиции для местного применения |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201691808A EA201691808A8 (ru) | 2014-03-11 | 2015-03-11 | Кортикостероидные композиции для местного применения |
Country Status (13)
Country | Link |
---|---|
US (4) | US20150258119A1 (ru) |
EP (2) | EP3116473B1 (ru) |
JP (2) | JP6487949B2 (ru) |
KR (2) | KR101930244B1 (ru) |
CN (1) | CN106659682B (ru) |
AU (2) | AU2015229403B2 (ru) |
BR (1) | BR112016021023A2 (ru) |
CA (2) | CA2945943C (ru) |
EA (2) | EA201691808A8 (ru) |
ES (1) | ES2857602T3 (ru) |
MX (2) | MX2016011842A (ru) |
WO (2) | WO2015138650A1 (ru) |
ZA (1) | ZA201606704B (ru) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2637447T3 (es) | 2009-08-31 | 2017-10-13 | Dr. Reddy's Laboratories Ltd. | Formulaciones tópicas que contienen un esteroide |
US20160184431A1 (en) | 2014-03-11 | 2016-06-30 | Promius Pharma Llc | Topical compositions comprising a corticosteroid |
WO2017091168A1 (en) * | 2015-11-28 | 2017-06-01 | Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. | A topical spray comprising isoconazole nitrate and difluocortolone valerate |
EP3405174A4 (en) * | 2016-01-12 | 2019-10-30 | Nortic Holdings Inc. | FORMATION OF BETAETHASONE FOR ORAL SPRAY AND USE THEREOF FOR THE TREATMENT OF ATAXIA |
GB201604316D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
WO2018020385A1 (en) * | 2016-07-27 | 2018-02-01 | Sun Pharmaceutical Industries Limited | Touch-free topical spray of halobetasol |
CA3037582A1 (en) | 2016-09-21 | 2018-03-29 | Avexxin As | Pharmaceutical composition |
US10543177B2 (en) * | 2017-04-11 | 2020-01-28 | Kevin Mrohs | Composition and method for treating skin conditions |
EP3752992A4 (en) | 2018-02-19 | 2021-12-08 | InVue Security Products, Inc. | GOODS SECURING SYSTEM WITH INDUCTIVE CHARGING |
JP2022508512A (ja) * | 2018-09-28 | 2022-01-19 | ジョエル スタディン | ステロイド及び巨大分子の経穴送達 |
JP7412292B2 (ja) * | 2019-07-10 | 2024-01-12 | 積水化学工業株式会社 | 製剤 |
WO2021080527A1 (en) * | 2019-10-24 | 2021-04-29 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Topical pharmaceutical compositions containing difluocortolone and isoconazole |
WO2021162796A1 (en) * | 2020-02-11 | 2021-08-19 | Taro Pharmaceutical Industries Ltd. | Compositions comprising desoximetasone and tazarotene |
US11382863B2 (en) * | 2020-03-04 | 2022-07-12 | Somerset Therapeutics Llc | Injectable suspension comprising an insoluble corticosteroid and a soluble corticosteroid |
CN113092601B (zh) * | 2021-03-02 | 2022-12-20 | 苏州市药品检验检测研究中心 | 一种化妆品中倍他米松17-丙酸酯及倍他米松21-丙酸酯的检测方法 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3892856A (en) | 1974-04-10 | 1975-07-01 | Squibb & Sons Inc | Topical steroid formulation |
US3934013A (en) | 1975-02-21 | 1976-01-20 | Syntex (U.S.A.) Inc. | Pharmaceutical composition |
US4343798A (en) | 1981-06-23 | 1982-08-10 | The Procter & Gamble Company | Topical antimicrobial anti-inflammatory compositions |
US4552872A (en) * | 1983-06-21 | 1985-11-12 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing corticosteroids |
WO1991008733A1 (en) * | 1989-12-20 | 1991-06-27 | Schering Corporation | Stable cream and lotion bases for lipophilic drug compositions |
IT1247529B (it) | 1991-04-24 | 1994-12-17 | Poli Ind Chimica Spa | Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale |
ES2180599T3 (es) | 1994-09-30 | 2003-02-16 | Mika Pharma Ges Fur Die Entwic | Composicion farmaceutica. |
GB9504265D0 (en) | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
IL152486A0 (en) * | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US20080206161A1 (en) * | 2002-10-25 | 2008-08-28 | Dov Tamarkin | Quiescent foamable compositions, steroids, kits and uses thereof |
US7820145B2 (en) * | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
CL2004001884A1 (es) * | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
ZA200507018B (en) * | 2003-12-16 | 2008-02-27 | Foamix Ltd | Oleaginous pharmaceutical and cosmetic foam |
AU2005279704B2 (en) * | 2004-08-31 | 2010-05-13 | Stiefel Research Australia Pty Ltd | Microemulsion and sub-micron emulsion process and compositions |
CA2756674C (en) * | 2004-08-31 | 2012-04-03 | Stiefel Research Australia Pty Ltd | Microemulsion & sub-micron emulsion process & compositions |
US20060246098A1 (en) * | 2005-03-16 | 2006-11-02 | Srinivasa Rao | Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same |
US20060239929A1 (en) | 2005-04-25 | 2006-10-26 | Dow Gordon J | Use of a clobetasol spray formulation to treat psoriasis |
GB2443162B (en) | 2006-10-28 | 2011-02-09 | Nupharm Lab Ltd | Betamethasone spray |
ES2637447T3 (es) * | 2009-08-31 | 2017-10-13 | Dr. Reddy's Laboratories Ltd. | Formulaciones tópicas que contienen un esteroide |
WO2011039637A2 (en) * | 2009-10-02 | 2011-04-07 | Foamix Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
NL2004437C2 (en) * | 2010-03-19 | 2011-09-20 | Forte Iq B V | Spray-pumpable comprising composition suitable for topical skin application. |
CA2802041A1 (en) * | 2010-06-11 | 2011-12-15 | Precision Dermatology, Inc. | High oil-content emollient aerosol foam compositions |
SG11201500988VA (en) * | 2012-08-10 | 2015-04-29 | Asahi Glass Co Ltd | Method for producing carbonate compound and method for producing aromatic polycarbonate |
CA2905587A1 (en) * | 2013-03-15 | 2014-09-18 | Medicis Pharmaceutical Corporation | Topical compositions of flunisolide and methods of treatment |
US10111956B2 (en) * | 2013-06-03 | 2018-10-30 | Tolmar, Inc. | Corticosteroid compositions |
-
2015
- 2015-03-11 BR BR112016021023-9A patent/BR112016021023A2/pt not_active Application Discontinuation
- 2015-03-11 JP JP2016575611A patent/JP6487949B2/ja not_active Expired - Fee Related
- 2015-03-11 WO PCT/US2015/020031 patent/WO2015138650A1/en active Application Filing
- 2015-03-11 KR KR1020167028054A patent/KR101930244B1/ko active IP Right Grant
- 2015-03-11 US US14/645,338 patent/US20150258119A1/en not_active Abandoned
- 2015-03-11 ES ES15712008T patent/ES2857602T3/es active Active
- 2015-03-11 EA EA201691808A patent/EA201691808A8/ru unknown
- 2015-03-11 MX MX2016011842A patent/MX2016011842A/es unknown
- 2015-03-11 CA CA2945943A patent/CA2945943C/en active Active
- 2015-03-11 EP EP15712008.0A patent/EP3116473B1/en active Active
- 2015-03-11 AU AU2015229403A patent/AU2015229403B2/en not_active Ceased
- 2015-09-09 EA EA201692334A patent/EA201692334A1/ru unknown
- 2015-09-09 WO PCT/US2015/049244 patent/WO2016144381A1/en active Application Filing
- 2015-09-09 CN CN201580035342.XA patent/CN106659682B/zh not_active Expired - Fee Related
- 2015-09-09 KR KR1020167030914A patent/KR101930246B1/ko active IP Right Grant
- 2015-09-09 MX MX2016011841A patent/MX2016011841A/es unknown
- 2015-09-09 US US14/849,465 patent/US20160030450A1/en not_active Abandoned
- 2015-09-09 CA CA2946201A patent/CA2946201C/en active Active
- 2015-09-09 EP EP15884898.6A patent/EP3197432A4/en not_active Withdrawn
- 2015-09-09 JP JP2017516360A patent/JP6535735B2/ja not_active Expired - Fee Related
- 2015-09-09 AU AU2015385750A patent/AU2015385750B2/en not_active Ceased
-
2016
- 2016-09-28 ZA ZA2016/06704A patent/ZA201606704B/en unknown
-
2018
- 2018-04-20 US US15/958,368 patent/US20180250312A1/en not_active Abandoned
-
2019
- 2019-08-27 US US16/551,872 patent/US20200230155A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201692334A1 (ru) | Кортикостероидные композиции для местного применения | |
CL2018001685A1 (es) | Compuestos heterociclicos como inmuno moduladores. | |
CO2017001493A2 (es) | Kits que comprenden inhibidores tigit y agentes anticáncer | |
PH12018500586A1 (en) | Farnesoid x receptor agonists and uses thereof | |
MX2021001439A (es) | Composiciones y metodos para el tratamiento de la disfuncion de la glandula de meibomio. | |
NI201600071A (es) | Compuestos de inhibidor de autotaxina | |
GT201500294A (es) | Compuestos de biaril-amida como inhibidores de cinasa | |
NI201600051A (es) | Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores | |
CO2018001375A2 (es) | Composiciones de retinoides tópicos | |
BR112016022318A2 (pt) | método, composição farmacêutica para uso no tratamento de doenças de retina e uso de um anticorpo | |
CL2015003801A1 (es) | Formulaciones de anticuerpos y metodos | |
MX2017005861A (es) | Metodos para el control transcripcional objetivo en regiones del super mejorador. | |
PH12017500239A1 (en) | Abiraterone acetate formulation and methods of use | |
PL410665A1 (pl) | Inhibitory arginazy oraz ich zastosowania terapeutyczne | |
NI201600070A (es) | Inhibidores tetracíclicos de autotaxina | |
MY193312A (en) | Topical formulation for promoting wound healing | |
EA201792571A1 (ru) | Терапевтическое применение l-4-хлорокинуренина | |
MX2018000262A (es) | Usos terapeuticos de formulaciones de berberina. | |
GT201400146A (es) | Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides | |
BR112018012349A2 (pt) | composição farmacêutica espumante, composição espumante de armazenamento estável e método para tratar um indivíduo com, ou em risco de ter, uma doença, condição ou distúrbio da pele | |
EA201991866A1 (ru) | Комбинированная терапия | |
PH12020500472A1 (en) | Autotaxin inhibitor compounds | |
MX2018002449A (es) | Formulaciones de liberacion retardada, metodos de fabricacion y uso de las mismas. | |
UA106471U (uk) | Засіб для лікування дерматологічних захворювань | |
IN2014DE00648A (ru) |